Peer Review reports
From: Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
| Original Submission | ||
|---|---|---|
| 9 Apr 2024 | Submitted | Original manuscript |
| 16 Apr 2024 | Author responded | Author comments - Qi Ru |
| Resubmission - Version 2 | ||
| 16 Apr 2024 | Submitted | Manuscript version 2 |
| 20 Apr 2024 | Author responded | Author comments - Qi Ru |
| Resubmission - Version 3 | ||
| 20 Apr 2024 | Submitted | Manuscript version 3 |
| 26 Apr 2024 | Author responded | Author comments - Qi Ru |
| Resubmission - Version 4 | ||
| 26 Apr 2024 | Submitted | Manuscript version 4 |
| 16 Jul 2024 | Reviewed | Reviewer Report |
| 25 Jul 2024 | Reviewed | Reviewer Report - Tarana Gupta |
| 8 Aug 2024 | Author responded | Author comments - Qi Ru |
| Resubmission - Version 5 | ||
| 8 Aug 2024 | Submitted | Manuscript version 5 |
| 10 Aug 2024 | Reviewed | Reviewer Report |
| 19 Aug 2024 | Reviewed | Reviewer Report |
| 28 Aug 2024 | Author responded | Author comments - Qi Ru |
| Resubmission - Version 6 | ||
| 28 Aug 2024 | Submitted | Manuscript version 6 |
| 29 Aug 2024 | Reviewed | Reviewer Report |
| 2 Sep 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 4 Sep 2024 | Editorially accepted | |
| 30 Sep 2024 | Article published | 10.1186/s12876-024-03402-9 |
You can find further information about peer review here.